Literature DB >> 1174282

Indomethacin inhibition of bumetanide diuresis in dogs.

U B Olsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174282     DOI: 10.1111/j.1600-0773.1975.tb00823.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  10 in total

1.  Effects of prostaglandin synthetase inhibition on natriuresis induced by diuretics and sodium loading in the rat [proceedings].

Authors:  M J Cooling; M F Sim
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

2.  Application of effect-compartment model to bumetanide-indomethacin interaction in dogs.

Authors:  D E Smith; H S Lau; J L Fox
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

Review 3.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

4.  Interaction between diuretics and indomethacin.

Authors:  S G Allan; J Knox; F Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

5.  Development of acute tolerance to bumetanide: constant-rate infusion studies.

Authors:  J A Cook; D E Smith
Journal:  Pharm Res       Date:  1988-02       Impact factor: 4.200

6.  Acute effects of acetylsalicylic acid on renal function in normal man.

Authors:  K J Berg
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

7.  Effect of bumetanide, frusemide and prostaglandin E2 on the isolated perfused kidney of rat and rabbit.

Authors:  J M Foy; S Z Nuhu
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

8.  Effect of inhibitors of prostaglandin synthesis on the furosemide action in the loop Henle of rat kidney.

Authors:  J Greven; A Farjam
Journal:  Pflugers Arch       Date:  1988-05       Impact factor: 3.657

Review 9.  Resistance to diuretics: emphasis on a pharmacological perspective.

Authors:  D C Brater
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

Review 10.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.